首页> 外文期刊>Pharmaceutical Biology >Pharmacokinetics of cisplatin in the absence or presence of Zengmian Yiliu granules (a traditional Chinese medicine compound) in rats determined via ICP-MS: An investigation on drug-herb interactions
【24h】

Pharmacokinetics of cisplatin in the absence or presence of Zengmian Yiliu granules (a traditional Chinese medicine compound) in rats determined via ICP-MS: An investigation on drug-herb interactions

机译:ICP-MS测定大鼠中是否存在增眠溢流颗粒(中药化合物)时顺铂的药代动力学:药-药相互作用的研究

获取原文
获取原文并翻译 | 示例
           

摘要

Context: Cisplatin is a highly effective chemotherapeutic agent against many tumors; however, it has potent adverse effects. Zengmian Yiliu granule (ZMYL), a traditional Chinese medicine (TCM) compound, has been clinically used against platinum (Pt)-induced toxicity and to enhance the efficacy of cisplatin.
机译:背景:顺铂是一种针对多种肿瘤的高效化疗药物。但是,它具有潜在的不利影响。增眠一流颗粒(ZMYL)是一种中药(TCM)化合物,已在临床上用于对抗铂(Pt)诱导的毒性并增强顺铂的疗效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号